Mediwound Ltd Ord Sh (MDWD)

$18.12 +0.02 (0.11%)
Market Cap 232.70M
Revenue (ttm) 20.22M
Net Income (ttm) -30.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.46%
Debt to Equity Ratio 0.02
Volume 59,400
Avg Vol 108,458
Day's Range N/A - N/A
Shares Out 12.84M
Stochastic %K 66%
Beta 0.07
Analysts Strong Sell
Price Target $31.50

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and ot...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 797 14100
Fax: 972 7 797 14111
Address:
42 Hayarkon Street, Yavne, Israel
novelty
novelty Jan. 30 at 1:56 PM
$MDWD now that our bearish back test has completed we drill through 16$
0 · Reply
novelty
novelty Jan. 30 at 12:04 AM
$MDWD always sell 18’s
0 · Reply
novelty
novelty Jan. 28 at 3:08 PM
$MDWD 18$ now refuses to move .10c. Lmao
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 2:35 PM
$MDWD RSI: 39.73, MACD: -0.1837 Vol: 0.87, MA20: 17.87, MA50: 18.13 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
novelty
novelty Jan. 26 at 5:59 PM
$MDWD 18.8$ for all the marbles
0 · Reply
JohnPDaly
JohnPDaly Jan. 26 at 3:21 PM
$LCTX $MDWD As time goes on, I get more and more convinced that the right method of investment is to put fairly large sums into enterprises which one thinks one knows something about and in the management of which one thoroughly believes.” — John Maynard Keynes
0 · Reply
JohnPDaly
JohnPDaly Jan. 23 at 3:53 PM
$MDWD This doesn’t even require patience, just basic reading skills.
0 · Reply
novelty
novelty Jan. 21 at 3:09 PM
$MDWD our little Bidless warrior
0 · Reply
novelty
novelty Jan. 21 at 2:39 PM
$MDWD pukeit
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 8:04 PM
$MDWD Excellent article that nails exactly where MDWD stands right now. So if you want to update your MDWD knowledge or get acquainted with MDWD, this is a must read. https://everyticker.com/quote/MDWD/analysis/mediwound-s-enzymatic-edge-faces-the-scale-test-nasdaq-mdwd
0 · Reply
Latest News on MDWD
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 22 days ago

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

Dec 10, 2025, 7:00 AM EST - 7 weeks ago

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

Nov 20, 2025, 10:43 AM EST - 2 months ago

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 20, 2025, 7:00 AM EST - 2 months ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

MediWound to Report Third Quarter 2025 Financial Results

Nov 5, 2025, 7:30 AM EST - 3 months ago

MediWound to Report Third Quarter 2025 Financial Results

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Nov 3, 2025, 8:00 AM EST - 3 months ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 29, 2025, 8:37 AM EDT - 4 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 25, 2025, 7:30 AM EDT - 4 months ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Sep 2, 2025, 7:30 AM EDT - 5 months ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

MediWound Is A Buy Opportunity On The Dip

Sep 2, 2025, 5:42 AM EDT - 5 months ago

MediWound Is A Buy Opportunity On The Dip

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 7:30 AM EDT - 5 months ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 1:31 PM EDT - 6 months ago

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 7:00 AM EDT - 6 months ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 13, 2025, 8:45 AM EDT - 6 months ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

MediWound to Report Second Quarter 2025 Financial Results

Aug 4, 2025, 7:30 AM EDT - 6 months ago

MediWound to Report Second Quarter 2025 Financial Results

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 12:46 PM EDT - 9 months ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 21, 2025, 7:00 AM EDT - 9 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

MediWound Ltd.: Undervalued High-Growth Potential

May 16, 2025, 10:34 AM EDT - 9 months ago

MediWound Ltd.: Undervalued High-Growth Potential

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 13, 2025, 7:30 AM EDT - 9 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

MediWound to Report First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 9 months ago

MediWound to Report First Quarter 2025 Financial Results

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Apr 28, 2025, 8:00 AM EDT - 10 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 12:10 PM EDT - 11 months ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 7:00 AM EDT - 11 months ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 25, 2025, 8:00 AM EST - 1 year ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 24, 2025, 8:00 AM EST - 1 year ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:12 AM EST - 1 year ago

MediWound to launch Phase III trial for venous leg ulcers

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Feb 12, 2025, 7:00 AM EST - 1 year ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

MediWound Is A Healthy Investment

Oct 29, 2024, 10:49 AM EDT - 1 year ago

MediWound Is A Healthy Investment

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Oct 10, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:15 PM EDT - 1 year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:00 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 14, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 5, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

MediWound to Report Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 29, 2024, 8:00 AM EDT - 1 year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 16, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:32 AM EDT - 1 year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

MediWound Announces $25 Million Strategic Private Placement Financing

Jul 15, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces $25 Million Strategic Private Placement Financing

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 29, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

MediWound to Report First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2024 Financial Results

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Apr 25, 2024, 8:00 AM EDT - 1 year ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 11:35 AM EDT - 2 years ago

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 21, 2024, 7:00 AM EDT - 2 years ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Mar 14, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Feb 12, 2024, 7:00 AM EST - 2 years ago

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

MediWound to Participate in Two Upcoming Investor Conferences

Feb 5, 2024, 8:00 AM EST - 2 years ago

MediWound to Participate in Two Upcoming Investor Conferences

novelty
novelty Jan. 30 at 1:56 PM
$MDWD now that our bearish back test has completed we drill through 16$
0 · Reply
novelty
novelty Jan. 30 at 12:04 AM
$MDWD always sell 18’s
0 · Reply
novelty
novelty Jan. 28 at 3:08 PM
$MDWD 18$ now refuses to move .10c. Lmao
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 2:35 PM
$MDWD RSI: 39.73, MACD: -0.1837 Vol: 0.87, MA20: 17.87, MA50: 18.13 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
novelty
novelty Jan. 26 at 5:59 PM
$MDWD 18.8$ for all the marbles
0 · Reply
JohnPDaly
JohnPDaly Jan. 26 at 3:21 PM
$LCTX $MDWD As time goes on, I get more and more convinced that the right method of investment is to put fairly large sums into enterprises which one thinks one knows something about and in the management of which one thoroughly believes.” — John Maynard Keynes
0 · Reply
JohnPDaly
JohnPDaly Jan. 23 at 3:53 PM
$MDWD This doesn’t even require patience, just basic reading skills.
0 · Reply
novelty
novelty Jan. 21 at 3:09 PM
$MDWD our little Bidless warrior
0 · Reply
novelty
novelty Jan. 21 at 2:39 PM
$MDWD pukeit
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 20 at 8:04 PM
$MDWD Excellent article that nails exactly where MDWD stands right now. So if you want to update your MDWD knowledge or get acquainted with MDWD, this is a must read. https://everyticker.com/quote/MDWD/analysis/mediwound-s-enzymatic-edge-faces-the-scale-test-nasdaq-mdwd
0 · Reply
novelty
novelty Jan. 20 at 5:29 PM
$MDWD nothing bullish til it can reclaim 19
1 · Reply
novelty
novelty Jan. 20 at 2:06 PM
$MDWD max short any back test higher. Doubt we get it tho, probably just drills In a straight line to 13$
0 · Reply
novelty
novelty Jan. 20 at 2:05 PM
$MDWD on our way to break the yearly 13 low. Dont listen to ur friends who kept pumping this to u
0 · Reply
novelty
novelty Jan. 20 at 2:02 PM
$MDWD sub 15’s do a little dance boys
0 · Reply
novelty
novelty Jan. 19 at 2:22 PM
$MDWD 100 point gapper down on spx should get us down to 15’s today
0 · Reply
novelty
novelty Jan. 17 at 5:11 PM
$MDWD how’s our Bidless warrior Holding up friends? 😂
0 · Reply
novelty
novelty Jan. 16 at 9:37 PM
$MDWD h&s break on weekly
0 · Reply
novelty
novelty Jan. 16 at 9:32 PM
$MDWD they’re coming to break the yearly 14 low. Enjoy the ride
0 · Reply
novelty
novelty Jan. 16 at 9:01 PM
$MDWD someone wants out in a hurry
0 · Reply
novelty
novelty Jan. 16 at 8:58 PM
$MDWD another massive dump at the lows. Hahahha
0 · Reply
novelty
novelty Jan. 16 at 8:37 PM
$MDWD does this stock even bounce? Lmao
0 · Reply
novelty
novelty Jan. 16 at 8:18 PM
$MDWD NUKED
0 · Reply